Odyssey Health, Inc.
ODYY
$0.01
$0.00-5.56%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 47.02% | -12.67% | -59.53% | -51.03% | -79.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.50% | -11.61% | -60.22% | -52.29% | -79.30% |
| Operating Income | -49.50% | 11.61% | 60.22% | 52.29% | 79.30% |
| Income Before Tax | 74.91% | 69.04% | 8.77% | -106.91% | -228.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 74.91% | 69.04% | 8.77% | -106.91% | -228.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.91% | 69.04% | 8.77% | -106.91% | -228.39% |
| EBIT | -49.50% | 11.61% | 60.22% | 52.29% | 79.30% |
| EBITDA | 75.21% | 67.36% | 76.47% | 52.33% | 79.32% |
| EPS Basic | 75.48% | 69.75% | -367.44% | -324.32% | -213.74% |
| Normalized Basic EPS | -290.74% | -262.50% | 55.78% | 59.57% | 78.99% |
| EPS Diluted | 70.72% | 66.17% | 34.81% | 16.38% | -261.97% |
| Normalized Diluted EPS | -320.37% | -262.50% | 50.00% | 55.56% | 77.50% |
| Average Basic Shares Outstanding | 1.85% | 1.28% | 3.68% | 9.78% | 15.73% |
| Average Diluted Shares Outstanding | 20.62% | 1.28% | -1.67% | 3.77% | 9.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |